R&D Chronic kidney disease: Challenges and upcoming technologies Highlighting the impact of kidney disease, and promoting awareness and research, is crucial.
R&D Inside out – the coming of age of organ-on-a-chip technology Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations.
Sales & Marketing Global upswing in medical writing, with a bout of M&A Swift pharma R&D growth has accelerated growth of associated industries, like medical writing.
R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
R&D A look back at RNA Therapeutics – day one The 14th Annual RNA Therapeutics Conference took place in Kensington, London this year.
News Reed pops up at J&J after leaving Sanofi Straight after John Reed's Sanofi exit, he has reappeared as head of pharma R&D at J&J
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
